Adalimumab; 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges; 40 mg/0.8 mL injection, 2 x 0.8 mL syringes; 40 mg/0.8 mL injection, 6 x 0.8 mL cartridges; 40 mg/0.8 mL injection, 6 x 0.8 mL syringes; Humira®

Page last updated: 1 November 2015

•    Public Summary Document (PSD) July 2015 PBAC Meeting - (PDF 661 KB)
•    Public Summary Document (PSD) July 2015 PBAC Meeting - (Word 100 KB)